Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Finance

Case Study: Algeta's lessons

How HealthCap, Abingworth apply lessons from successful Algeta investment

February 10, 2014 8:00 AM UTC

When the $2.9 billion acquisition of Algeta ASA by Bayer AG closes in two weeks, an investor who got in early and one who got in late both stand to reap gigantic multiples. Both HealthCap and Abingworth say they are applying lessons they learned while helping to build Algeta in hopes of replicating that success in other investments.

Algeta raised a total of $275 million in a series A round, an IPO, two private placements and a bond offering...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article